Past Activities 2015-2016

Again, I like Dr. Sidarenka's approach on how to capture the nature of what we should be considering as "synthetic biology" or  "artificial biology".

If we keep discussing in details all the possible techniques for "genetic change", genetic recombination or genetic modification, trying to be as much inclusive as possible, we will lose focus on the real need ( or not ) of specific measures of risk assessment and risk management for artificial biology, mixing artificial biology with the old biotech and even the genetic improvement in the conventional sense.